Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu-Pei Liao

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Frontiers in Bioscience : a Journal and Virtual Library|May 9, 2007
Modification of the tumor microenvironment to enhance immunityYu-Pei Liao, Dorthe Schaue, William H McBride
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 11, 2025
KRAS mRNA Spleen-Targeting Lipid Nanoparticles Synergize with Irinotecan Silicasomes to Robustly Augment the Cancer Immunity Cycle in Pancreatic CancerLijia Luo, Xiang Wang, Yu-Pei Liao, et al.
ACS Nano|November 22, 2025
Reprogramming Immunosuppressive Niches and the Cancer Immunity Cycle in Pancreatic Cancer with Neoantigen mRNA Plus Immune Adjuvant Nanocarrier StrategiesAndré E Nel, Lijia Luo, Yu-Pei Liao, et al.
Bioengineering (Basel, Switzerland)|October 28, 2023
Use of Stromal Intervention and Exogenous Neoantigen Vaccination to Boost Pancreatic Cancer Chemo-Immunotherapy by NanocarriersSaborni Chattopadhyay, Yu-Pei Liao, Xiang Wang, et al.
ACS Nano|March 29, 2022
Multifunctional Lipid Bilayer Nanocarriers for Cancer Immunotherapy in Heterogeneous Tumor Microenvironments, Combining Immunogenic Cell Death Stimuli with Immune Modulatory DrugsAndré E Nel, Kuo-Ching Mei, Yu-Pei Liao, et al.
ACS Nano|March 3, 2025
Reprogramming the Tolerogenic Immune Response Against Pancreatic Cancer Metastases by Lipid Nanoparticles Delivering a STING Agonist Plus Mutant KRAS mRNAXiao Xu, Xiang Wang, Yu-Pei Liao, et al.
Anticancer Research|March 25, 2010
Immune rejection in a humanized model of murine prostate cancerDörthe Schaue, Richard C Koya, Yu-Pei Liao, et al.
ACS Nano|August 3, 2022
Nanocarrier Co-formulation for Delivery of a TLR7 Agonist plus an Immunogenic Cell Death Stimulus Triggers Effective Pancreatic Cancer Chemo-immunotherapyLijia Luo, Xiang Wang, Yu-Pei Liao, et al.
Immunology|September 11, 2009
Local irradiation of murine melanoma affects the development of tumour-specific immunityYu-Pei Liao, Chun-Chieh Wang, Dörthe Schaue, et al.
ACS Nano|February 28, 2023
Use of a Liver-Targeting Immune-Tolerogenic mRNA Lipid Nanoparticle Platform to Treat Peanut-Induced Anaphylaxis by Single- and Multiple-Epitope Nucleotide Sequence DeliveryXiao Xu, Xiang Wang, Yu-Pei Liao, et al.
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Frontiers in Bioscience : a Journal and Virtual Library|May 9, 2007
Modification of the tumor microenvironment to enhance immunityYu-Pei Liao, Dorthe Schaue, William H McBride
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 11, 2025
KRAS mRNA Spleen-Targeting Lipid Nanoparticles Synergize with Irinotecan Silicasomes to Robustly Augment the Cancer Immunity Cycle in Pancreatic CancerLijia Luo, Xiang Wang, Yu-Pei Liao, et al.
ACS Nano|November 22, 2025
Reprogramming Immunosuppressive Niches and the Cancer Immunity Cycle in Pancreatic Cancer with Neoantigen mRNA Plus Immune Adjuvant Nanocarrier StrategiesAndré E Nel, Lijia Luo, Yu-Pei Liao, et al.
Bioengineering (Basel, Switzerland)|October 28, 2023
Use of Stromal Intervention and Exogenous Neoantigen Vaccination to Boost Pancreatic Cancer Chemo-Immunotherapy by NanocarriersSaborni Chattopadhyay, Yu-Pei Liao, Xiang Wang, et al.
ACS Nano|March 29, 2022
Multifunctional Lipid Bilayer Nanocarriers for Cancer Immunotherapy in Heterogeneous Tumor Microenvironments, Combining Immunogenic Cell Death Stimuli with Immune Modulatory DrugsAndré E Nel, Kuo-Ching Mei, Yu-Pei Liao, et al.
ACS Nano|March 3, 2025
Reprogramming the Tolerogenic Immune Response Against Pancreatic Cancer Metastases by Lipid Nanoparticles Delivering a STING Agonist Plus Mutant KRAS mRNAXiao Xu, Xiang Wang, Yu-Pei Liao, et al.
Anticancer Research|March 25, 2010
Immune rejection in a humanized model of murine prostate cancerDörthe Schaue, Richard C Koya, Yu-Pei Liao, et al.
ACS Nano|August 3, 2022
Nanocarrier Co-formulation for Delivery of a TLR7 Agonist plus an Immunogenic Cell Death Stimulus Triggers Effective Pancreatic Cancer Chemo-immunotherapyLijia Luo, Xiang Wang, Yu-Pei Liao, et al.
Immunology|September 11, 2009
Local irradiation of murine melanoma affects the development of tumour-specific immunityYu-Pei Liao, Chun-Chieh Wang, Dörthe Schaue, et al.
ACS Nano|February 28, 2023
Use of a Liver-Targeting Immune-Tolerogenic mRNA Lipid Nanoparticle Platform to Treat Peanut-Induced Anaphylaxis by Single- and Multiple-Epitope Nucleotide Sequence DeliveryXiao Xu, Xiang Wang, Yu-Pei Liao, et al.
Pageof 7